The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain
Ocul Surf
12 Jan 2021
https://pubmed.ncbi.nlm.nih.gov/33450415/
Low-dose Naltrexone (LDN) & Chronic Pain (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.
Dr. Adrienne Junek, MD, CCFP, ABOIM
Low-dose Naltrexone (LDN) & Chronic Pain
A potential anti-inflammatory effect of low-dose naltrexone in fibromyalgia
J Pain
01 April 2015
https://www.jpain.org/article/S1526-5900(15)00362-4/abstract
Low dose naltrexone in refractory neuropathic pain associated with autoimmune transverse myelitis
J Pain
01 April 2015
https://www.jpain.org/article/S1526-5900(15)00354-5/fulltext
A case of transverse myelitis (TM) with secondary central pain syndrome refractory to multiple pain medications and immune-modulation therapies, which responded to low dose (3-4.5 mg) Naltrexone.